In a statement, Mounjaros manufacturer, Eli Lilly, said, Patient safety is Lillys top priority, and we actively engage in monitoring, evaluating, and reporting safety information for all our medicines
The average starting weight for both groups was ~232 lbs
Avoid greasy, spicy, processed, and fried foods
Not Reaching Weight Loss Goals About In the same trial, Persistent Side Effects Another reason for switching to a different weight loss medication is experiencing severe side effects that dont improve
Among patients who switched from AOM tirzepatide to a different GLP-1, the majority transitioned to AOM semaglutide, aligning with its status as the CVS Caremark preferred therapy